Business Description
ADARx Pharmaceuticals is a San Diego-based clinical-stage biotech company, founded in 2019, that develops RNA-based medicines targeting a wide range of serious diseases. Its lead programs include treatments aimed at hereditary angioedema, stroke prevention, and a liver-focused therapy with the potential to address multiple conditions. The company is also advancing earlier-stage programs targeting obesity and Alzheimer's disease. All of its work is built on a shared technology platform designed to deliver these therapies precisely to the intended tissues in the body.
